UPDATE: Coronado Biosciences (CNDO) Files 2M Common Stock Offering
Tweet Send to a Friend
Up)
(Updated - June 4, 2012 8:10 AM EDT)
CORRECTION: Coronado Biosciences (Nasdaq: CNDO) filed a registration statement with the U.S. Securities and Exchange Commission for of its Common Stock. Coronado will sell 2 million shares.
The offering is being made through Oppenheimer & Co., National Securities Corp., and Roth Capital Partners.
Coronado is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
CORRECTION: Coronado Biosciences (Nasdaq: CNDO) filed a registration statement with the U.S. Securities and Exchange Commission for of its Common Stock. Coronado will sell 2 million shares.
The offering is being made through Oppenheimer & Co., National Securities Corp., and Roth Capital Partners.
Coronado is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
